Implement a dual-wheel drive strategy of leveraging the strengths of innovative vaccine development
and traditional vaccine upgrading and a R&D strategy of laying equal stress on independent development and joint development.
The Vaccine Research Institute of the Company has two R&D platforms in Chengdu West High-tech Zone and Chengdu Tianfu International Bio-town, with a total area of nearly 10,000 square meters, which is capable to research and develop biological products such as bacterial vaccines, viral vaccines, nucleic acid vaccines and new adjuvants. At the same time, the Company has been keeping close cooperation with domestic and foreign research institutes, and has set up joint vaccine development laboratories in Chongqing and Australia. In recent years, the Company has been awarded the honorary titles of “National Enterprise with Advantage in IPRs”, “Enterprise Technology Center in Sichuan” and “Enterprise Technology Center in Chengdu City”. Upholding the innovative and open corporate culture, the Vaccine Research Institute of the Company will establish multi-dimensional cooperative relationships to jointly promote the development of the vaccine field and provide innovative and effective solutions against significant health issues faced by China and the world.
R&D innovation is the vitality of a company. The Company has practiced a R&D mode of “laying equal stress on independent development and joint development”. After years of research and development, the Company has set up a step-type product development pattern with three products launched, several products in clinical trials, and a number of other products as R&D reserve.
This product is indicated for the prevention against epidemic cerebrospinal meningitis caused by meningococci of Groups A and C, and for the prevention against invasive infection caused by Haemophilus Influenzae Type b, including meningitis, pneumonia, septicemia, cellulitis, arthritis and epiglottitis, etc.
This product is indicated for the prevention against skin, soft tissue and blood infections caused by Staphylococcus aureus.
